Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
24th February 2025 Uncategorised 0Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. Of the world’s 22 biopharma companies that have reported quarterly revenues of at least $2 billion, only one posted a year-over-year decline. And that decline came with a caveat.
More: Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Source: fierce